|
|
|
|
Science Sparks @ ACTREC
|
 8th January 2024 |
Vol. No. 13 ; Issue No.612 |
|
|
Publications
|
|
1. Natu A, Verma T, Khade B, Thorat R, Gera P, Dhara S, Gupta S (2024). Histone acetylation: A key determinant of acquired cisplatin resistance in cancer. Clinical Epigenetics. 16:8.
2. Dandia HY, Pillai MM, Sharma D, Suvarna M, Dalal N, Madhok A, Ingle A, Chiplunkar SV, Galande S, Tayalia P (2024). Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy. Military Medical Research.
3. Moharir S, Akotkar L, Aswar U, Kumar D, Gawade B, Pal K, Rane R (2024). Improved pharmacokinetic and pharmacodynamic profile of deuterium-reinforced tricyclic antidepressants doxepin, dosulepin, and clomipramine in animal models. European Journal of Drug Metabolism and Pharmacokinetics.
4. Kumar S, Castelino R, Rao A, Gattani S, Kumar A, Pillai A, Sehgal A, Rane P, Ramaswamy A, Dhekale R, Krishnamurthy J, Banavali S, Badwe R, Prabhash K, Noronha V, Gota V (2024). Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine.
5. Shinde U, De A, Godse R, Rathod M, Thorat R, Sharma N, Ansari M, Singh K (2024). Efficacy evaluation of carboplatin -etoposide Co-loaded PLGA microparticles for subconjunctival chemotherapy in retinoblastoma. Journal of Drug Delivery Science and Technology.
Theses
1. Dievya Dilip Gohil. 2023. Evaluation of phytochemicals with immunomodulatory activity for graft-versus-host disease prophylaxis. (LIFE09201604014) (Guide: Dr. Vikram Gota).
2. Suchita Dubey. 2023. Structural and functional basis to evaluate PML-RARA response to arsenic trioxide. (LIFE09201504008) (Guide: Dr. Ashok Varma).
|
|
|
|
|
Interesting Reads
|
|
Penter L, Borji M, Nagler A, Lyu H, Lu WS, Cieri N, Maurer K, Oliveira G, Al'Khafaji AM, Garimella KV, Li S, Neuberg DS, Ritz J, Soiffer RJ, Garcia JS, Livak KJ, Wu CJ. Integrative genotyping of cancer and immune phenotypes by long-read sequencing. Nat Commun. 15(1): 32, 2024.
|
|
|
Video of the Week
|
|
| The Elusive Role of Stellate Cells in Liver Cancer |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1993, Results from an NCI-supported clinical trial show that annual screening with guaiac fecal occult blood testing (FOBT) can reduce colorectal cancer mortality by about 33%.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Scientists show reprogrammed fat cells support tumor growth.
|
|
MedicalXpress, 03/01/20224
|
|
The researchers treated immature adipocytes with a culture medium in which breast cancer cells with or without p53 mutations had previously grown. This treatment triggered profound changes in metabolism and gene activity in the adipocytes and increased the production of pro-inflammatory messengers...
|
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
